Speaker illustration

Mr Peter Collins

Ipsos, London (United Kingdom of Great Britain & Northern Ireland)

Changes in the diagnostic landscape of transthyretin amyloid cardiomyopathy (ATTR-CM): a comparison of tests ordered and test Intervals in 2020 Q4 and 2023 Q4

Event: ESC Congress 2024

Topic: Infiltrative Myocardial Disease

Session: The different faces of cardiac amyloidosis

Thumbnail